COMMUNIQUÉS West-GlobeNewswire

Momenta Pharmaceuticals to Webcast Presentation at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that Craig Wheeler, President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference [...]
Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US
02/01/2019
Helsinn Group Announces new Permanent J Code for AKYNZEO ® (fosnetupitant and palonosetron) for injection in the US Akynzeo ® for injection received a permanent J code, J1454 , in the US, by the Centers for Medicare and [...]
Jounce Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
Eidos Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
SAN FRANCISCO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at the 37 th Annual J.P. Morgan Healthcare Conference on [...]
Genocea Doses First Patients and Completes Enrollment in Part A of Phase 1/2a Clinical Trial for Neoantigen Vaccine Candidate GEN-009
02/01/2019
First immunogenicity data now expected in mid-2019 CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies [...]
Solid Biosciences to Present at the J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Ilan Ganot, Co-Founder, Chief Executive Officer and President of Solid Biosciences will present at the 37th [...]
Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria
02/01/2019
-- Primary Efficacy Endpoint of Change in Urinary Oxalate Excretion at Four Weeks -- -- URIROX-2™, Second Pivotal Phase 3 Trial, Initiated in Fourth Quarter of 2018 -- -- URIROX-1™, First Pivotal Phase 3 Trial, [...]
Ceapro Inc. to Present at Biotech Showcase™ 2019
02/01/2019
Presentation with live audio webcast Tuesday, January 8, 2019 at 2:00 PM PST EDMONTON, Alberta, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology [...]
Sharecare to present at J.P. Morgan Healthcare Conference for sixth consecutive year
02/01/2019
ATLANTA, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced it will present at the 37th annual J.P. Morgan Healthcare Conference [...]
Merus Announces Strategic Collaboration with Betta Pharmaceuticals to Develop and Commercialize MCLA-129 in China
02/01/2019
Merus to retain all global rights outside of China Betta Pharmaceuticals to fund global IND-enabling activities UTRECHT, the Netherlands, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our [...]
Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer
02/01/2019
Dr. Brown previously served as Head of Global Pharmaceutical Development at Galderma and has over 25 years of experience leading clinical development programs Dermavant plans to initiate Phase 3 clinical program for [...]
HempAmericana CEO Issues 2019 Letter to Shareholders
02/01/2019
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, First off, we [...]
MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi
02/01/2019
Management to Host Conference Call at 8:30 a.m. ET/5:30 a.m. PT SOUTH SAN FRANCISCO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering [...]
gammaCore™ Now Available Through U.S. Federal Government’s Federal Supply Schedule (FSS)
02/01/2019
BASKING RIDGE, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced its non-invasive vagus nerve stimulation (nVNS) therapy, [...]
Daré Bioscience Provides Update for Investors on Development Programs and Anticipated 2019 Milestones
02/01/2019
Key anticipated 2019 clinical milestones: Topline results of Ovaprene® PCT clinical trial Initiation of at-home portion of Sildenafil Cream, 3.6% Phase 2b Initiation of pivotal Phase 3 study of DARE-BV1 SAN DIEGO, Jan. [...]
Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
ALPHARETTA, Ga., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Sarepta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today announced that management will present at the 37th Annual J.P [...]
Tauriga Sciences, Inc. Enters into Manufacturing Agreement for the Production of its Cannabis/CBD Infused Chewing Gum Product
02/01/2019
NEW YORK, NY, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
CymaBay Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
NEWARK, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Pages